Adiposity is not generally a risk factor for stroke
Professor Tobias Back MD is medical director of the Clinic for Neurology and Neurological Intensive Medicine in Arnsdorf, Germany.
Ethical concerns over clinical trials in India
As an increasing number of international drug companies are moving their clinical trials business to India, the clinical trial industry has been raising concerns about the lack of regulation of private trials carried out there, including the uneven application of requirements for informed consent and proper ethics review.
Pioneering software to protect patients' privacy
Information in patients' records could benefit biomedical research in terms of understanding diseases and their treatments. The drawback is that those records contain confidential information that could identify patients. If that data has to be removed manually, the task is not only painstaking and therefore expensive, but also not foolproof.
Patients views on pay for their personal self control
To reduce health costs as well as improve health, many large employers and insurers are introducing pay for the performance of patients (P4P4P).
Atrial fibrillation
Seeking to set the agenda for urgent atrial fibrillation (AF) research, European and international cardiologists will gather this October at the European Heart House, in Sophia Antipolis, the headquarters of the European Society of Cardiology.
Beijing Olympics research finds enlarged hearts can be good hearts
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
Drug might protect against tumour recurrence
Tumour cells can migrate, sometimes also during a surgery to remove the tumour. US researchers recently found, that perioperative treatment with a drug known as colchicine might protect against recurrences at the site of the surgical wound.
Good prospects for drug/radiation combo
It was a mistery: Why didn't drugs which boost the tumor-killing power of immune cells in lab do well in clincal trials? Now researchers from Rockefeller University describe a way to enhance the ability of these drugs by combining them with radiation therapy.
SlideCollector simplifies single cell gene expression
The SlideCollector 48 enables the seamless integration of non-contact Laser Capture Microdissection (LCM) and single-cell AmpliGrid assay technology into one continuous, automated workflow. This ensures the highest levels of sample purity for applications in immunobiology, genetics, cancer research, stem cell research and forensics.
Non invasive but effective
A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive angioplasty.
Prostate scanning too often performed?
Experts on a US panel expressed their doubts on the beneficial quality of prostate cancer screenings for elderly men. Prostate cancer often grows very slowly and may not kill an older man before he suffers from another death reason, they pointed out.
British medical research centres go into partnership
From September onwards, Europe's largest academic health science partnership will start its programm in London, UK. Their focus will lay on preventing and treating major diseases in 10 key areas.
New strategies against MRSA
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
Focus: hygiene and nosocomial infections
They are one of the major threats in today's hospital: tiny pathogens that hide out in catheters, in ventilation tubes, on instruments or on the keyboards of medical technological equipment only waiting to attack patients whose immune system is already weakened. This week, EH Online will take a closer look at nosocomial infections, their causes, their effects and the available ways and means to…
LIFE Nutrition founded
B. Braun Melsungen AG laid the foundation stone for a new manufacturing plant for production and development in nutrition solutions. The new production site includes a research lab and costs around 190 million Euro. In the future 270 employees will work on innovative denouements for the world market.
Eradiction of H. pylori protects against stomach cancer
Almost all stomach cancers not related to the heart develop from the stomach ulcer causing bug H. pylori. A Japanese study shows that treatment to eradicate the mikrobe reduces the risk of developing new gastric carcinoma in patients.
New treatment guidelines for HIV infection
An international panel of physicians has updated the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection after evaluating recent data, according to an article in JAMA, a theme issue on HIV/AIDS.
What hips tell about breast cancer
As rocks keep the secrets of the earth, bones might keep those of the body. A new study that will be publish in the September 1, 2008 issue of CANCER suggests, that factors responsible for higher bone mineral density might also lead to higher risk of breast cancer.
Wound dressing fights the super bug
In any hospital, one of the most dreaded enemies is MRSA. This super-resistant pathogen laughs in the face of most antibiotics. But now, medical and hygiene product manufacturer Lohmann & Rauscher may have developed an efficient weapon to fight this ugly beast: a wound dressing that contains polyhexamethylene biguanide (PHMB).
Happiness causes cancer?
Reseacher from the Univerisity of Zürich discovered a new function of the “happiness hormone”, serotonin. It boosts the growing of colon cancer by enhancing the vascular development of tumors.
Many more strokes
Even in 2004, the medical costs for the care of stroke patients in Germany came to 7.1 billion euro. The neurologist Tobias Neumann-Haefelin of the Johann Wolfgang Goethe University in Frankfurt and his colleagues have calculated the projected number of strokes in the German federal state of Hesse for the year 2050.
Agendia: New labs in Amsterdam
Last month Agendia announced the official opening of the company's new headquarters at Amsterdam's Science Park. The new facilities offer 13,000 square feet of laboratory and office space to support the company's molecular diagnostic cancer testing services and research activities.
New marker for diabetes
This week not only one but rather two studies report about a new and independent marker that is associated with type 2 diabetes. The protein that is called fetuin-A is produced in the liver and secreted to the blood stream also indicates a higher risk of developing diabetes disease.
Emergency admission: Who is affected?
Answer: Older men, living in high social deprivation who are treated for pain or infectious diseases are very endangered. That is the simplified result Scottish researchers investigated while trying to point out criterias that might predict the likelihood of emergency admission in adults older than 40 years
HDL cholesterol important for memory in a high age
High-Density-Lipoprotein-Cholesterol is a so-called "good" cholestoral because it seems to protect the vessels from fat deposits. Hereby they can prevent atherosclerosis. The Whitehall II Study in the UK searched for the specific connection between low level of HDL and dementia risk and published now their results.